Heres What Dragged Dentsply Sirona in Q4
| XRAY Stock | USD 19.63 0.01 0.05% |
Slightly above 62% of Dentsply Sirona's investor base is looking to short. The analysis of overall sentiment of trading Dentsply Sirona stock suggests that many investors are alarmed at this time. Dentsply Sirona's investing sentiment can be driven by a variety of factors including economic data, Dentsply Sirona's earnings reports, geopolitical events, and overall market trends.
Dentsply |
Heartland Advisors, an investment management company, released its Heartland Value Fund fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was up 1.97 percent in the fourth quarter compared to a 1.06 percent fall for the Russell 2000 Value Index. The fund outperformed the benchmark over the past 1, 3,
Read at finance.yahoo.com
 |
Dentsply Sirona Fundamental Analysis
We analyze Dentsply Sirona's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dentsply Sirona using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dentsply Sirona based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Dentsply Sirona is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Dentsply Sirona Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dentsply Sirona stock to make a market-neutral strategy. Peer analysis of Dentsply Sirona could also be used in its relative valuation, which is a method of valuing Dentsply Sirona by comparing valuation metrics with similar companies.
Peers
Dentsply Sirona Related Equities
| RMD | ResMed | 1.89 | ||||
| HAE | Haemonetics | 1.73 | ||||
| WST | West Pharmaceutical | 1.28 | ||||
| HOLX | Hologic | 1.06 | ||||
| TFX | Teleflex Incorporated | 1.04 | ||||
| ALC | Alcon AG | 1.03 | ||||
| BDX | Becton Dickinson | 0.64 | ||||
| COO | Cooper Companies, | 0.10 | ||||
| MMSI | Merit Medical | 0.30 | ||||
| ANGO | AngioDynamics | 0.40 | ||||
| ICUI | ICU Medical | 1.42 |
Additional Tools for Dentsply Stock Analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.